[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100454714":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":23,"locations":33,"responsibleParty":53,"collaborators":10,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":10,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Can-Am HIFU Inc.","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Rezum procedure",null,[12],"Procedure: Rezum",[14],{"type":15,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"PROCEDURE","Rezum",[9],[19],{"name":20,"affiliation":21,"role":22},"Dean Elterman","University Health Network, Toronto","PRINCIPAL_INVESTIGATOR",[24,30],{"name":25,"role":26,"phone":27,"phoneExt":28,"email":29},"Iris Chan","CONTACT","416-603-5800","5033","iris.chan2@uhn.ca",{"name":20,"role":26,"phone":31,"phoneExt":10,"email":32},"141660358005033","dean.elterman@uhn.ca",[34],{"facility":20,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Toronto","Ontario","M5T 2S8","Canada","CA",{"type":42,"coordinates":43},"Point",[44,45],-79.39864,43.70643,{"lat":45,"lon":44},[48,50,52],{"name":20,"role":26,"phone":49,"phoneExt":28,"email":32},"4166035800",{"name":25,"role":26,"phone":49,"phoneExt":51,"email":32},"Elterman",{"name":20,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":22,"investigatorFullName":20,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Urologist","100454714",false,"NCT05201131","Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Male subjects of ≥ 18 years of age.\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH).\n* Candidate for Rezūm therapy as per clinical decision of Investigator.\n* Willing and able to accurately complete the required questionnaires.\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":63,"type":64},50,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.",[68],"Urologic Diseases",[70],"benigh prostate hypertrophy","2022-01-07",{"date":73,"type":74},"2022-01-21","ACTUAL",{"date":76,"type":74},"2019-10-07",{"date":78,"type":64},"2026-12-31",{"name":5,"class":6},1]